Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BIBNASDAQ:FTXHNASDAQ:HEALNASDAQ:IBBQ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIBProShares Ultra Nasdaq Biotechnology$43.11-2.1%$43.93$33.78▼$69.56$47.42M1.6312,063 shs9,915 shsFTXHFirst Trust Nasdaq Pharmaceuticals ETF$25.30-0.7%$25.30$23.29▼$29.72$13.92M0.75,817 shs6,307 shsHEALGlobal X HealthTech ETF$10.35-1.0%$9.70$8.16▼$11.91$37.36M1.0823,196 shs214,352 shsIBBQInvesco Nasdaq Biotechnology ETF$20.44-0.9%$20.38$17.84▼$24.84$37.00M0.6117,351 shs29,481 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBIBProShares Ultra Nasdaq Biotechnology+2.15%-2.76%-1.26%-19.70%-22.27%FTXHFirst Trust Nasdaq Pharmaceuticals ETF+1.40%-0.77%+1.47%-9.18%-4.24%HEALGlobal X HealthTech ETF+2.35%-2.06%+10.12%+1,044,999,900.00%+1,044,999,900.00%IBBQInvesco Nasdaq Biotechnology ETF+0.93%-1.29%0.00%-8.52%-6.99%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBIBProShares Ultra Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AN/AN/AHEALGlobal X HealthTech ETFN/AN/AN/AN/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBIBProShares Ultra Nasdaq Biotechnology 2.76Moderate Buy$43.11N/AFTXHFirst Trust Nasdaq Pharmaceuticals ETF 2.60Moderate Buy$25.30N/AHEALGlobal X HealthTech ETF 2.70Moderate Buy$10.35N/AIBBQInvesco Nasdaq Biotechnology ETF 2.76Moderate Buy$20.44N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBIBProShares Ultra Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AHEALGlobal X HealthTech ETFN/AN/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBIBProShares Ultra Nasdaq BiotechnologyN/AN/A20.68∞N/AN/AN/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/A16.72∞N/AN/AN/AN/AN/AHEALGlobal X HealthTech ETFN/AN/A41.46∞N/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/AN/A23.20∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBIBProShares Ultra Nasdaq Biotechnology$0.942.18%N/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETF$0.481.90%N/AN/AN/AHEALGlobal X HealthTech ETFN/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETF$0.241.17%N/AN/AN/ALatest IBBQ, HEAL, BIB, and FTXH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/25/2025BIBProShares Ultra Nasdaq BiotechnologyQuarterly$0.13091.03%3/26/20253/26/20254/1/20253/26/2025FTXHFirst Trust Nasdaq Pharmaceuticals ETFQuarterly$0.09921.45%3/27/20253/27/20253/31/20253/24/2025IBBQInvesco Nasdaq Biotechnology ETF$0.04023/24/20253/24/20253/28/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBIBProShares Ultra Nasdaq BiotechnologyN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AHEALGlobal X HealthTech ETFN/AIBBQInvesco Nasdaq Biotechnology ETFN/AInsider OwnershipCompanyInsider OwnershipBIBProShares Ultra Nasdaq BiotechnologyN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AHEALGlobal X HealthTech ETFN/AIBBQInvesco Nasdaq Biotechnology ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBIBProShares Ultra Nasdaq BiotechnologyN/A1.10 millionN/AOptionableFTXHFirst Trust Nasdaq Pharmaceuticals ETF147,000550,000N/AOptionableHEALGlobal X HealthTech ETFN/A3.61 millionN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/A1.81 millionN/AOptionableIBBQ, HEAL, BIB, and FTXH HeadlinesRecent News About These CompaniesU.S. Nuclear Push and AI Demand Ignite Uranium ETF RallyMay 27 at 3:46 PM | theglobeandmail.comInvesco Nasdaq Biotechnology ETF declares quarterly distribution of $0.04021March 24, 2025 | msn.com5 Undervalued ETFs to Ride on Powell's Market OptimismMarch 20, 2025 | zacks.comWhen the Price of (IBBQ) Talks, People ListenJanuary 26, 2025 | news.stocktradersdaily.comTrading (IBBQ) With Integrated Risk ControlsJanuary 6, 2025 | news.stocktradersdaily.comInvesco Nasdaq Biotechnology ETF declares quarterly distribution of $0.0619December 23, 2024 | msn.com(IBBQ) Trading SignalsDecember 4, 2024 | news.stocktradersdaily.comInvesco Launches New ETFs Targeting AI, Cybersecurity, And Defense. Here's How Some Of Their Peers Have Performed In The Past YearNovember 7, 2024 | msn.comLong Term Trading Analysis for (IBBQ)November 2, 2024 | news.stocktradersdaily.comHow the (IBBQ) price action is used to our AdvantageOctober 23, 2024 | news.stocktradersdaily.comIBBQ Invesco Nasdaq Biotechnology ETFOctober 21, 2024 | seekingalpha.comUpstream Bio valued at $1.1 bln as shares jump in Nasdaq debutOctober 11, 2024 | reuters.com(IBBQ) Proactive StrategiesOctober 11, 2024 | news.stocktradersdaily.com(IBBQ) Investment Analysis and AdviceOctober 1, 2024 | news.stocktradersdaily.com(IBBQ) Investment AnalysisSeptember 20, 2024 | news.stocktradersdaily.comImmuneSensor Therapeutics to Participate in the UBS 2024 Virtual Biotechnology Private Company SymposiumSeptember 16, 2024 | markets.businessinsider.comWhere are the Opportunities in (IBBQ)August 24, 2024 | news.stocktradersdaily.comPiper lists eight defensive biotechs to face market volatilityAugust 11, 2024 | msn.comIs The Invesco QQQ Right For Your Stock Portfolio? How To DecideJuly 25, 2024 | forbes.comHow to Invest in Invesco QQQ TrustMay 13, 2024 | fool.comMedia Sentiment Over TimeTop HeadlinesView All HeadlinesUnitedHealth Insiders Double Down: Is UNH Stock a Value Play?By Jeffrey Neal Johnson | May 19, 2025View UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Analysts Think These Stocks Could More Than Double in ValueBy Nathan Reiff | May 23, 2025View Analysts Think These Stocks Could More Than Double in Value3 Trades Members of Congress Are Making Right NowBy Chris Markoch | May 23, 2025View 3 Trades Members of Congress Are Making Right NowWill Hims & Hers Stock Be Okay After UnitedHealth's Sell-Off?By Gabriel Osorio-Mazilli | May 22, 2025View Will Hims & Hers Stock Be Okay After UnitedHealth's Sell-Off?Archer Posts Surprise Q1 Beat, Sets Stage for 2025 Revenue LaunchBy Jeffrey Neal Johnson | May 14, 2025View Archer Posts Surprise Q1 Beat, Sets Stage for 2025 Revenue LaunchIBBQ, HEAL, BIB, and FTXH Company DescriptionsProShares Ultra Nasdaq Biotechnology NASDAQ:BIB$43.11 -0.94 (-2.13%) Closing price 03:59 PM EasternExtended Trading$43.94 +0.83 (+1.93%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.First Trust Nasdaq Pharmaceuticals ETF NASDAQ:FTXH$25.30 -0.19 (-0.74%) Closing price 03:37 PM EasternExtended Trading$25.30 0.00 (0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.Global X HealthTech ETF NASDAQ:HEAL$10.35 -0.10 (-0.96%) As of 03:59 PM EasternAn ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.Invesco Nasdaq Biotechnology ETF NASDAQ:IBBQ$20.44 -0.18 (-0.87%) Closing price 04:00 PM EasternExtended Trading$20.42 -0.03 (-0.12%) As of 07:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock GameStop Buys Bitcoin: Smart Strategy or Big Mistake? Qualcomm Stock Turns South: 3 Entry Signals to Watch For D-Wave Quantum Stock: Are Advantage2 Gains Here to Stay? Meta's Institutional & Insider Data Fuels Bulls Despite Disparity Is Michael Burry Right Betting Against the Market Again? Amer Sports: The New ONON and DECK of Consumer Discretionary? BigBear.ai: Risky AI Stock or Defense Tech Opportunity? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
